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We  evaluated  the  effects  of  cigarette  smoke  (CS)  on  lung  inﬂammation  and  remodeling  in  a model  of
ovalbumin  (OVA)-sensitized  and  OVA-challenged  mice.  Male  BALB/c  mice  were  divided  into  4  groups:
non-sensitized  and  air-exposed  (control);  non-sensitized  and  exposed  to  cigarette  smoke  (CS),  sensitized
and air-exposed  (OVA)  (50  g +  OVA  1% 3  times/week  for  3 weeks)  and  sensitized  and  cigarette  smoke
exposed  mice  (OVA +  CS).  IgE  levels  were  not  affected  by  CS exposure.  The  increases  in total  bronchoalve-rowth factors
nﬂammation
emodeling
olar  ﬂuid  cells  in  the  OVA  group  were  attenuated  by  co-exposure  to CS,  as were  the  changes  in  IL-4,  IL-5,
and  eotaxin  levels  as  well  as  tissue  elastance  (p <  0.05).  In contrast,  only the  OVA  + CS  group  showed  a  sig-
niﬁcant  increase  in  the  protein  expression  of  IFN-,  VEGF,  GM-CSF  and collagen  ﬁber content  (p  <  0.05).  In
our study,  exposure  to  cigarette  smoke  in OVA-challenged  mice  resulted  in  an  attenuation  of  pulmonary
inﬂammation  but led to  an  increase  in  pulmonary  remodeling  and  resulted  in  the  dissociation  of  airway
inﬂammation  from  lung  remodeling.. Introduction
Epidemiologic studies have shown that tobacco smoke con-
ributes to the development and increased severity of asthma
Melgert et al., 2004; Moerloose et al., 2005). Cigarette smoke
xposure results in more frequent asthma attacks and symptoms,
mpairment in lung function and decreased efﬁcacy of short-term
nhaled corticosteroid treatment in steroid-naïve patients with
sthma (Althius et al., 1999; James et al., 2004; Siroux et al., 2000).
lthough some clinical trials suggest that smokers have a lower risk
f developing asthma symptoms when compared with nonsmok-
rs and ex-smokers (Hjern et al., 2001; McWhorter et al., 1989;
soumakidou et al., 2007), such ﬁndings should be interpreted
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569-9048 © 2012 Elsevier B.V. Open access under the Elsevier OA license.carefully due to the behavior of some aspects of the asthmatic
inﬂammatory process (Churg et al., 2006; Trimble et al., 2009).
Studies with animal models involving cigarette smoke and allergic
asthma have shown conﬂicting results, especially regarding lung
inﬂammation and remodeling (Melgert et al., 2004; Min  et al., 2007;
Moerloose et al., 2005; Robbins et al., 2005). Some studies have
shown that short-term exposure to environmental tobacco smoke
in experimental models of asthma in mice induces augmented lev-
els of airway remodeling associated with an increase of eosinophils
in bronchoalveolar lavage ﬂuid (Min  et al., 2007; Moerloose et al.,
2005). However, others have demonstrated a decrease of inﬂamma-
tory cells after short-term smoke exposure in allergic mice (Melgert
et al., 2004; Robbins et al., 2005).
Airway inﬂammation and lung remodeling are distinguishing
features observed in both clinical and experimental asthma, as
well as in cigarette smoke exposure, and these features are clearly
related to airﬂow obstruction (Churg et al., 2006). The pathogene-
sis of airway inﬂammation and lung remodeling in lung disorders
© 2012 Elsevier B.V. Open access under the Elsevier OA license.involving cigarette exposure is a ﬁeld fraught with disagreement
(Jeffery, 2001). There are two  main schools of thought on the sub-
ject: one holds that lung remodeling is a response to repeated
inﬂammatory injuries caused by cigarette smoke exposure and
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epresents a trend toward developing abnormal inﬂammatory
eactions to small stimuli (Jeffery, 2001). This point of view
ccounts for changes in airway structure as an exaggerated heal-
ng process by inﬂammatory cells. Another perspective is that lung
emodeling is a product of the excessive release of growth factors
e.g., TGF- and collagen types I and III), leading to an incremental
ncrease in ﬁbrotic tissue and muscle thickness. These growth fac-
ors could be a direct response to the provocative agents mediated
y chronic injury or repair of airway epithelium but not directly dic-
ated by the inﬂammatory response (Chapman, 2004; Churg et al.,
006; Gauldie et al., 2002; Kenyon et al., 2003; Selman et al., 2001).
hese ﬁndings suggest that inﬂammation and ﬁbrosis may  occur
ndependently (Chapman, 2004; Gauldie et al., 2002; Selman et al.,
001).
Therefore, we reasoned that cigarette smoke exposure could
ause opposite effects on airway inﬂammation, responsiveness and
ulmonary remodeling in asthma. In the present study, we  used
n experimental model of allergic inﬂammation in BALB/c mice to
nvestigate the effects of three weeks of mild cigarette smoke expo-
ure on pulmonary inﬂammation and lung remodeling when both
timuli (i.e., allergen challenge and cigarette smoke) are adminis-
ered simultaneously.
. Methods
.1. Animals and experimental design
Thirty-one male BALB/c mice (20–25 g) from the vivarium of
he School of Medicine, University of Sao Paulo were divided into
 groups as follows: animals non-sensitized and air-exposed (con-
rol group, n = 8); animals non-sensitized and exposed to cigarette
moke (CS group, n = 7); animals sensitized and air-exposed (OVA
roup, n = 7); and animals sensitized and exposed to cigarette
moke (OVA + CS group, n = 9). This study was approved by the
eview Board for Human and Animal Studies of the School of
edicine of the University of Sao Paulo. All animal care and exper-
mental procedures followed the EU Directive, 2010/63/EU for
nimal experiments guidelines (Ofﬁcial Journal of the European
nion, 2010).
.2. OVA model
We  used a modiﬁed OVA protocol from Vieira et al. (2007).
ALB/c mice were sensitized by intraperitoneal (i.p.) injection
f aluminum hydroxide-adsorbed ovalbumin (OVA) (50 g per
ouse) or saline (NaCl 0.9%) on days 0, 14 and 28. Twenty-one
ays after the ﬁrst i.p. injection, mice were exposed to aerosolized
VA (1%) or saline 3 times per week for 30 min  in the morning until
ay 42 (Fig. 1A).
.3. Cigarette smoke exposure
We used a modiﬁed cigarette smoke exposure protocol from
iselli et al. (2011) beginning 21 days after the ﬁrst immunization
nd lasting until day 42, as in the OVA protocol. CS and OVA + CS
ice were exposed to cigarette smoke for 30 min  per day and 5
ays per week for 3 weeks in the afternoon (Fig. 1A and B). The ﬂow
ate was set at 1.5 L/min, which produced carbon monoxide (CO)
evels ranging from 300 to 350 ppm and resulted in blood levels of
arboxyhemoglobin of 10%.
.4. Respiratory mechanicsForty-eight hours after the last challenge, the animals were
nesthetized with pentobarbital sodium (50 mg/kg i.p.), and a tra-
heotomy was performed. The mice were then connected to a Neurobiology 181 (2012) 167– 176
ventilator for small animals (ﬂexiVent, Scireq, Quebec, Canada)
with the tidal volume and frequency set at 20 mL/kg and 2 Hz,
respectively. After 1 min, the animals were paralyzed with pan-
curonium bromide (1 mg/kg), and the anesthetic level was checked
during the entire procedure. Oscillatory lung mechanic measure-
ments were performed to obtain airway resistance (Raw), small
airway resistance (Gtis) and tissue elastance (Htis) (Hantos et al.,
1992).
2.4.1. Methacholine dose–response curve
Different methacholine concentrations, ranging from 6 to
50 mg/mL, were delivered by an ultrasonic device over 1 min
(Respira Max, NS, LTDA, Sao Paulo, Brazil). After 30 s, respiratory
mechanics data were collected. A response curve for bronchial
responsiveness was performed immediately after the metha-
choline challenge, and bronchoalveolar ﬂuid (BALF) and blood were
collected. The animals were euthanized by rapid exsanguination via
the abdominal aorta while anesthetized.
2.5. Measurement of serum IgE
Total serum IgE was measured using an enzyme-linked
immunosorbent assay (ELISA) kit (Pharmingen, San Diego, CA) fol-
lowing the manufacturerıˇs protocol.
2.6. Total and differential cell counting in bronchoalveolar lavage
ﬂuid (BALF)
The lungs were gently lavaged with 3 instillations of 0.5 mL of
phosphate buffered saline (PBS, pH 7.2) via tracheal cannula. Total
cells were counted in a Neubauerıˇs hemocytometer chamber. Dif-
ferential cell counts of 300 cells/animal were obtained after Diff
Quick staining of BALF prepared on slides. All measurements were
taken in a blinded fashion.
2.7. Bio-Plex assay for IL-4, IL-5, eotaxin, IL-10, IFN- , GM-CSF
and VEGF from lung tissue
A mouse 7-Plex cytokine assay kit (Millipore Laboratories, Inc.,
Merck KGaA, Darmstadt, Germany) was  used to test samples for
the presence of 7 cytokines. The assay was  read on the Bio-Plex
suspension array system. The data were normalized to the amount
of input tissue.
2.8. Lung histology and morphometry
The right lungs were ﬁxed in formalin and embedded in paraf-
ﬁn. Five-micrometer-thick sections were stained with picrosirius
red (PS) for collagen ﬁbers. Immunohistochemistry (IHC) was
performed with anti-IL4, anti-IL-5, anti-IL-10 and anti-TGF- anti-
bodies (Santa Cruz, CA), as previously described (de Magalhães
Simoes et al., 2005). Measurements of collagen content and IHC-
positive cells were performed with imaging analysis software
(Image-Pro Plus, 4.5.0.29 for Windows, Media Cybernetics, Sil-
ver Spring, MD)  on images acquired from a light microscope
with a digital camera connected to a computer (Leica DMR; Leica
Microsystems, Wetzlar GmbH, Wetzlar, Germany). Analyses were
made from ﬁve images of a transversally cut airway and its adja-
cent vascular structure. The collagen content was measured within
the adventitial space between the airway and the adjacent blood
vessel (peribronchovascular space) as the collagen area divided by
the respective basement membrane length (m2/m = m).  IL-4-
and IL-5-positive cells were also measured in the peribronchovas-
cular space, where the inﬁltration by inﬂammatory cells in this
murine model is more intense (Vieira et al., 2007; Arantes-Costa
et al., 2008). TGF-- and IL-10-positive cells were measured in the
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Fig. 1. (A) Experimental design of the study: 3 ovalbumin injections were administrated on days 0, 14 and 28. From days 21 to 42, the animals were exposed to aerosolized
OVA  or saline (3 days/week for 30 min) in the morning and to cigarette smoke (5 days/week for 30 min) in the afternoon; 48 h later, anesthetized mice were euthanized. (B)
Cigarette smoke exposure device (modiﬁed from Biselli et al., 2011): cigarette smoke exposure was  performed in a 28-L plastic box with two inlets (for air and smoke), one
outlet  and a fan (for the enhancing air and smoke mixture inside the box). In the ﬁrst inlet, we applied synthetic air (2 L/min). The second inlet received synthetic air that
passed  through a Venturi valve connected to a lit cigarette that suctioned the cigarette smoke and pumped it inside the box.
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nd airway lumen. Cell density was assessed as the number of pos-
tive cells divided by the respective basement membrane length
cells/m) in 5 bronchovascular structures at a ×400 magniﬁca-
ion. All morphometric measurements were performed in a blinded
ashion.
.9. Statistical analyses
Comparisons among groups were performed by a one-way anal-
sis of variance followed by Tukey’s post hoc test (parametric data)
r by a one-way analysis of variance on ranks followed by Dunn’s
ost hoc test (non-parametric data). The signiﬁcance level was
djusted to 5% (p < 0.05). The correlation between the number of
GF--positive cells in the bronchial epithelium and collagen ﬁber
ontent was performed using Pearson’s correlation. For statistical
nalyses, we used the Sigma Stat 3.5 Software (San Jose, CA).3. Results
3.1. CS attenuates the eosinophilic inﬂammation induced by OVA
independent of IgE
OVA exposure resulted in a signiﬁcant increase in lung
eosinophils, neutrophils, lymphocytes and macrophages (Table 1).
The increases in neutrophils, lymphocytes and macrophages in the
BALF were not observed in the group that was exposed to both oval-
bumin and cigarette smoke (OVA + CS group). Exposure to cigarette
smoke also attenuated the increase in eosinophils induced by OVA
exposure; therefore, the numbers of eosinophils observed in the
BALF of the OVA + CS group were signiﬁcantly greater than in the
CS group but lower than in the OVA group.There was  an increase in total serum IgE in both of the sensi-
tized mouse groups (OVA and OVA + CS groups) compared with the
control and CS groups (p < 0.001). Cigarette smoke exposure did not
affect this increase in IgE (Fig. 2).
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Table  1
Findings of the bronchoalveolar lavage ﬂuid.
Control CS OVA OVA + CS
Total cells (×104/mL) 3.07 ± 1.48 2.61 ± 0.49 19.72 ± 13.51* 5.20 ± 1.63
Eosinophils (×104/mL) 0.05 ± 0.14 0.01 ± 0.00 2.73 ± 0.58* 0.33 ± 0.08**
Neutrophils (×104/mL) 0.07 ± 0.03 0.04 ± 0.05 0.39 ± 0.03* 0.10 ± 0.13
Macrophages (×104/mL) 2.23 ± 1.15 1.97 ± 0.25 8.94 ± 1.15* 3.72 ± 1.66
Lymphocytes (×104/mL) 0.58 ± 0.31 0.17 ± 0.07 2.91 ± 1.57* 0.43 ± 0.23
Deﬁnition of abbreviations: Control, saline (n = 8); CS, cigarette smoke; (n = 7) OVA, ovalbumin (n = 7); OVA + CS, ovalbumin + cigarette smoke exposure (n = 9). Values are
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ceported as mean ± SD.
* p < 0.005 versus all Control and OVA + CS experimental groups.
** p < 0.001 versus the CS group.
.2. Decreased tissue elastance after CS exposure in
VA-challenged mice
OVA exposure resulted in higher values of tissue elastance
Htis) compared with the control and CS groups (p < 0.05) (Fig. 3A).
he values of Htis after methacholine challenge were signiﬁ-
antly greater in the OVA group compared with the control group
p < 0.008 at concentrations of 6, 12 and 25 mg/mL, and p < 0.05
t basal levels and 50 mg/mL). No signiﬁcant increase in pul-
onary elastance response was observed in the OVA + CS group
ompared with the control and CS groups. There were no sig-
iﬁcant differences in the Gtis (small airways resistance) or Raw
airways resistance) values among the four experimental groups
Fig. 3B and C).
.3. Effects of OVA and CS exposure on cytokine expression
IL-4 levels in the lung tissue were increased in the OVA group
hen compared with all of the other groups (p < 0.04) (Fig. 4A).
he OVA group also showed a signiﬁcant increase in IL-4-positive
ells in the peribronchovascular compartment (p = 0.01 compared
ith the control group, Fig. 4B). There was no signiﬁcant difference
etween the OVA and OVA-CS groups (p = 0.06).
The co-exposure to cigarette smoke did not increase IL-5 lev-
ls in the lung tissue or the number of IL-5 positive cells in the
eribronchovascular space (Fig. 4C and D, respectively). The OVA
roups showed a signiﬁcant increase in IL-5 levels in the lung tissue
hen compared with all of the other groups (p = 0.004); however,
his difference could not be detected in the peribronchovascular
pace, despite graphic similarities (p = 0.06).
Cigarette smoke exposure did not increase eotaxin levels in the
ung tissue (Fig. 4E). The OVA group showed a signiﬁcant increase
n eotaxin when compared with all of the other groups (p = 0.01). In
ig. 2. Serum IgE levels (means and SD). CS, mice exposed to cigarette smoke;
VA, mice exposed to ovalbumin; and OVA + CS, mice exposed to both ovalbumin
nd  cigarette smoke. The values are presented as the means ± SD. *p < 0.001 when
ompared with the Control and CS groups.
Fig. 3. Dose–response curves to inhaled methacholine solution (Mch). The
responses to Mch  are measured as Htis (tissue elastance), Gtis (tissue resistance)
and  Raw (airway resistance) (A, B and C, respectively). The values are presented as
the means ± SD. *p < 0.05 when compared with the control and CS groups, **p  < 0.008
compared with the control and CS groups.
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Fig. 4. (A) IL-4 levels from the lung tissue; (B) levels of IL-4-positive cells in the peribronchovascular compartment; (C) IL-5 levels from the lung tissue; (D) levels of IL-5-
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Tositive cells in the peribronchovascular compartment. No signiﬁcant differences w
issue.  The values are presented as the means ± SD. *p ≤ 0.04 when compared with 
ontrast, an increase in IFN- levels in the lung tissue was observed
n the OVA + CS group when compared with all of the other groups
p = 0.001) (Fig. 4F).
Fig. 5 shows a panel with the levels of IL-10 measured in the Bio-
lex assay and the numbers of IL-10-positive cells in the bronchial
pithelium (Fig. 5A and B, respectively). There was  an increase in
L-10 levels in the CS, OVA and OVA + CS groups, with the OVA + CS
roup signiﬁcantly different from all of the other groups (p = 0.001).
he CS and OVA groups also showed signiﬁcant differencesbserved; (E) eotaxin levels from the lung tissue; and (F) IFN- levels from the lung
he other groups; **p = 0.01 compared with the control group.
compared with the Control group (p < 0.05) (Fig. 5A). The abun-
dance of IL-10-positive cells was  also increased in the groups
exposed to cigarette smoke when compared with the Control group
(p < 0.05) (Fig. 5B).3.4. CS induces airway remodeling in OVA challenged mice
Exposure to ovalbumin resulted in a non-signiﬁcant increase
in collagen ﬁber content in the peribronchovascular area (p = 0.06
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Fig. 5. (A) IL-10 levels from the lung tissue; and (B) levels of IL-10-positive cells in
the  airway epithelium. The values are presented as the means ± SD. *p = 0.001 when
compared with all of the other groups; **p < 0.05 when compared with the control
group.
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compared with the control group, Fig. 6). Only the OVA + CS
roup showed a signiﬁcant increase of collagen ﬁber content
n the peribronchovascular area (p = 0.001 compared with the
ther three groups). Panels A–D show representative photomi-
rographs of collagen content in the bronchovascular structures
n the four experimental groups following staining for collagen
bers.
The OVA + CS group showed a signiﬁcant increase in the abun-
ance of TGF--positive cells in the bronchial epithelium (p < 0.005
ompared with the Control and CS groups, Fig. 7A). Isolated expo-
ure to either OVA or cigarette smoke did not increase the density
f TGF--positive cells in the epithelium. In addition, there was
 strong correlation between TGF--positive epithelial cells and
eribronchovascular collagen ﬁber content (Fig. 6) in the OVA + CS
roup (r = 0.91; p = 0.01). The cytokine assay also showed a signif-
cant increase in GM-CSF levels in the OVA + CS group compared
ith all of the other groups (p = 0.004) (Fig. 7B). Cigarette smoke
xposure also increased VEGF levels, as indicated in Fig. 7C. The
VA + CS group showed a signiﬁcant difference in VEGF levels com-
ared with the Control and OVA groups (p = 0.03). The CS group
howed a similar increase in VEGF levels when compared with the
ontrol mice (p = 0.01). Neurobiology 181 (2012) 167– 176
4. Discussion
In this study, we observed that short-term (3 weeks) exposure
to cigarette smoke in mice with pulmonary allergic inﬂammation
induced by ovalbumin exposure results in an attenuation of pul-
monary inﬂammation with a concomitant increase in pulmonary
remodeling.
We showed that ovalbumin exposure, with or without co-
administration of cigarette smoke, results in a comparable,
signiﬁcant increase in IgE (Fig. 2). The heightened response to Mch
observed in OVA-exposed mice was  abolished by co-exposure to
CS (Fig. 3). The pattern of cytokine release was quite distinctive
when CS was  added to OVA, with increases in IFN- (Fig. 4), IL-10
(Fig. 5), TGF-, GM-CSF and VEGF (Fig. 7). Peribronchovascular col-
lagen deposition (Fig. 6) was  also increased by OVA + CS exposure.
These ﬁndings suggest the dissociation of pulmonary inﬂammation
and remodeling in this experimental model.
We  used an experimental model of allergic pulmonary inﬂam-
mation that induced pulmonary inﬂammation. Evaluation of the
cells in the bronchoalveolar lavage ﬂuid revealed the presence of
a substantial increase in eosinophils, lymphocytes and neutrophils
(Table 1). Additionally, we observed an increase in total IgE levels
in the blood of mice that were exposed to ovalbumin, and the blood
levels of IgE were not inﬂuenced by exposure to cigarette smoke.
Exposure to cigarette smoke was  initiated only three weeks after
the ﬁrst intraperitoneal injection of ovalbumin because our goal
was to study the inﬂuence of cigarette smoke on the pulmonary
inﬂammation induced by exposure to an allergen and not on the
sensitization to the allergen. In addition, our purpose was  to expose
the mice to cigarette smoke for a short period that would not induce
pulmonary changes suggestive of chronic bronchitis or pulmonary
emphysema.
OVA exposure resulted in higher values of tissue elastance (Htis)
compared with the control and CS groups (p < 0.05) (Fig. 3A). This
difference was not observed in airway resistance (Raw) (Fig. 3C).
This ﬁnding is not surprising; in this experimental model, inﬂam-
mation predominantly occurs in the pulmonary tissue around the
airways and in the adjacent blood vessels but not in the bronchial
wall (Vieira et al., 2007; Arantes-Costa et al., 2008). The increase
in the elastance response to methacholine observed in the mice
exposed to ovalbumin was observed for tissue elastance (Htis)
but not for airway (Raw) or tissue (Gtis) resistance. Exposure
to cigarette smoke attenuated the elastance response to metha-
choline in mice exposed to ovalbumin. This decrease in pulmonary
elastance response may  be due to the attenuation of pulmonary
inﬂammation and/or the increase in remodeling. The relationship
between eosinophilic inﬂammation and airway and/or pulmonary
responsiveness has been well studied both in humans with asthma
and in experimental animals with allergic inﬂammation (Bento and
Hershenson, 1998; Chen et al., 2003; Niimi et al., 2003; Palmans
et al., 2000). The decrease in the number of eosinophils inﬁltrat-
ing the lungs in response to cigarette smoke exposure possibly
inﬂuenced the responsiveness to inhaled methacholine (O’Byrne,
1997).
We observed an increase in peribronchovascular collagen ﬁber
content in mice that were exposed to both ovalbumin and cigarette
smoke. Palmans et al. (2000) showed the deposition of extracellular
matrix components, such as collagen or ﬁbronectin, in the airway
walls of sensitized rats subjected to repeated exposures to aller-
gens. This increase in extracellular matrix component deposition
may  be associated with attenuated airway smooth muscle (ASM)
shortening due to stiffening of the airways. Postmortem studies
showed that the ASM layer of patients with asthma is thickened.
This may  result in airway hyperresponsiveness if the contractil-
ity of ASM cells remains constant. However, thickening of the ASM
layer is partly attributed to the increased deposition of extracellular
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fig. 6. Collagen ﬁber content in the peribronchovascular space of the lungs in the fo
re  presented as the means ± SD. *p = 0.001 when compared with the other three ex
tained  with picrosirius in all of the groups. A, Control; B, CS; C, OVA and D, OVA + C
atrix around individual ASM cells, which may  act against ASM
hortening (Bento and Hershenson, 1998; Chen et al., 2003; Niimi
t al., 2003; Palmans et al., 2000). Thus, it is plausible that the
ttenuation in tissue elastance observed in the OVA + CS group in
his experimental model is related to an increase in collagen ﬁber
ontent.
Exposure to cigarette smoke can also result in airway remod-
ling. Churg et al. exposed mice to different periods of cigarette
moke (2 h, 6 h, 24 h, 1 week, 1 month and 6 months) and noted that
 h after cigarette smoke exposure, there was an approximately six-
old increase in type 1 procollagen gene expression, although thiserimental groups. The results are expressed as the area by length (m). The values
ental groups. Panels A–D show representative photomicrographs of collagen ﬁbers
increase declined over 24 h. Following chronic exposure, there was
an approximately eightfold increase in the expression of this gene.
The same pattern was observed in the expression of connective tis-
sue growth factor (CTGF) and TGF-1 (Churg et al., 2006). However,
after 2 h of exposure to cigarette smoke, these changes abate ini-
tially and then show a subtle new increase after 1 week, remaining
close to the initial values after 6 months of exposure. These data can
partially explain our ﬁndings because 3 weeks of cigarette smoke
exposure alone was  not enough to increase collagen ﬁber content.
We observed a signiﬁcant increase in TGF--positive cells in the
bronchial epithelium only in the CS + OVA group after 3 weeks of
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Fig. 7. (A) TGF--positive cells in the airway epithelium. Five ﬁelds of bronchial
epithelium per animal were analyzed. (B) GM-CSF levels from the lung tissue. (C)
VEGF levels in the lung tissue. The values are presented as the means ± SD. *p < 0.005
when compared with the control and CS groups; #p = 0.004 compared with all of74 D.C. Hizume et al. / Respiratory Physio
igarette smoke exposure, suggesting an additive or synergic effect
f both stimuli (Min  et al., 2007). Interestingly, in this group of
ice, there was a strong positive correlation between the den-
ity of cells in the bronchial epithelium expressing TGF- and the
ensity of collagen ﬁbers (r = 0.91; p = 0.01). Previous studies both
n vivo and in vitro revealed a relationship between TGF-beta in
he bronchial epithelium and lung remodeling with particularly
ncreased expression of types I and III collagen (Kenyon et al., 2003).
hese ﬁndings support the idea that TGF- can cause lung remod-
ling even in the absence of detectable inﬂammation.
In our model, we also observed an increase in GM-CSF and
EGF levels in the OVA + CS group. GM-CSF is a cytokine that inﬂu-
nces the proliferation and differentiation of bone marrow cells.
he mechanism by which GM-CSF induces collagen synthesis is
ot completely clear, but it could be due to induction of TGF-, a
nown regulator of connective tissue synthesis. GM-CSF was  shown
o induce TGF- mRNA expression in vascular smooth muscle
nd in leiomyoma cells (Brown et al., 2001). These data corrob-
rate our ﬁndings, reinforcing the observed increase in the lung
emodeling in the OVA + CS group. VEGF is involved in angiogene-
is and remodeling and is an autocrine survival factor for epithelial
ells (St-Laurent et al., 2009). St-Laurent et al. (2009) studied the
ronchial epithelial cells from challenged OVA-sensitized rats and
howed an increase in VEGF after 5 days of cigarette smoke extract
xposure, and the cigarette smoke-exposed groups also had an
ncrease in VEGF levels. Our data compares favorably with reports
rom cell-based studies (Brown et al., 2001) that showed an increase
n VEGF levels in groups exposed to cigarette smoke and reinforce
he increase in pulmonary remodeling in this experimental model.
Cigarette smoke is known to have immunomodulatory proper-
ies, but the extent to which smoking cigarettes can alter airway
mmunity in asthma is not well established (Trimble et al., 2009).
ur results showed a signiﬁcant difference in IFN- levels in the
VA + CS group compared with all of the other groups. CS stimuli
lone were insufﬁcient to produce an increase in lung IFN- levels,
uggesting an additional effect of CS on allergic lung inﬂamma-
ion. Although this most likely reﬂects the toxic effects of cigarette
moke, it is noteworthy that IFN- did not abolish, but decreased
igniﬁcantly, the eosinophilic inﬂammation as expected (Cho et al.,
005; Hofstra et al., 1998; Sopori and Kozak, 1998). In addition,
levated levels of IFN- were found in the sputum of patients with
sthma, also suggesting that the pathology of asthma could be par-
ially IFN- driven (Cho et al., 2005; Sopori and Kozak, 1998).
Many chemical components of cigarette smoke can affect
mmune function (Sopori and Kozak, 1998; Nouri-Shirazi et al.,
007). One of the most potent and reactive cigarette smoke
omponents is acrolein. Acrolein can inﬂuence IL-10, a cytokine
ith regulatory and anti-inﬂammatory characteristics capable
f inhibiting antigen presentation in macrophages/monocytes
Hristova et al., 2012). This inhibition results in the abrogation of
roliferative responses and a decrease in T cell cytokine production
Li et al., 1997, 1999; Li and Holian, 1998; Seymour et al., 1997). This
echanism may  be involved in our experimental model because
nimals exposed to cigarette smoke showed high levels of cytokines
n the lung tissue and elevated expression of IL-10 in the bronchial
pithelial cells (Kasahara et al., 2008).
In contrast, the expression of IL-4 and IL-5 (Th-2-related
ytokines) and eotaxin (an eosinophil chemotactic factor) was
ncreased in peribronchiolar leukocytes, and the total levels of
L-4 and IL-5 were increased in the lung homogenates of OVA-
xposed mice, but these levels were not affected by cigarette
moke. The mechanisms by which cigarette smoke attenuates
irway eosinophilia are not currently understood. Trimble et al.
2009) observed robust eosinophilic airway inﬂammation in
ice that were exposed to smoke over a sensitization period
nly, while eosinophilic airway inﬂammation was attenuated bythe  other groups; **p = 0.03 when compared with the control and OVA groups and
/= p = 0.01 when compared with the control group.
continuous cigarette smoke exposure (Trimble et al., 2009). These
ﬁndings imply that cigarette smoke has both adjuvant and anti-
inﬂammatory properties in models of allergic airway inﬂammation.
Moerloose et al. (2005) observed an exacerbation of the inﬂam-
matory responses in animals exposed to smoke (Moerloose et al.,
2005). The reasons for these discordant results are unclear. Dif-
ferences in the experimental approaches may  partially explain
these results. Seymour et al. (1997) suggested that exposure to
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ainstream cigarette smoke or environmental tobacco smoke
ETS) can result in different effects on inﬂammation and sensiti-
ation. In their experiment, they observed that exposure of mice
o ETS up-regulated allergic responses to inhaled allergens, while
ainstream exposure to cigarette smoke (similar to our experi-
ental model) could act in an opposite way (Seymour et al., 1997).
In our experimental model, we observed an increase in the elas-
ance response to a nebulized methacholine solution in the OVA
roup. This increase in pulmonary responsiveness was observed
hen Htis was measured but not when Raw was studied, sug-
esting that the site of the response was in the lung parenchyma
nd/or distal airways and not in the central airways. Peták et al.
1997) studied the effects of methacholine-induced bronchocon-
triction in rats in response to intravenous (i.v.) versus aerosol
dministration and suggested that Mch  acts on distinct structures
hen delivered by inhalation or i.v. Mch  produces a muscle con-
raction by stimulating the muscarinic cholinergic receptors (Peták
t al., 1997). Sly et al. (1995) investigated the role of the mus-
arinic receptors in puppies and observed that different receptors
ay  be involved in producing airway and parenchymal constriction
n response to inhaled Mch. M3  receptors located on the airway
mooth muscle are likely to be responsible for airway responses
nd may  be more easily reached by i.v.-delivered Mch, whereas
ch  delivered by the aerosol route must diffuse across the respi-
atory epithelium before reaching the muscle (Barnes, 1993). In
ontrast, M1  receptors in the alveolar wall, which are reported to be
nvolved in the parenchymal response (Sly et al., 1995), are likely to
e reached more easily by aerosol delivery than by the i.v. route. In
ur experimental model, the observed increase in the pulmonary
esponse to aerosolized methacholine in the ovalbumin-exposed
ice was abolished when there was also cigarette smoke
xposure.
Recent studies have shown that airway hyperresponsiveness
an be dissociated from cellular inﬂammation while remaining
inked to airway remodeling, and some previous reports also
uggested that airway inﬂammation, lung remodeling and respon-
iveness may  not be directly interrelated (Alcorn et al., 2007; Crimi
t al., 1998). Particularly, Alcorn et al. (2007) suggested that atten-
ated airway remodeling does not impact airway inﬂammatory
esponses or airway responsiveness. Corroborating these ﬁndings,
enyon et al. (2003) showed that animals that received a TGF-1
nstillation had increased the expression of types I and III collagen
s well as the total collagen content in the small airways. Notably,
here were no signs of inﬂammation detected in this process. These
ndings suggest that inﬂammation and pulmonary remodeling
ay  occur independently (Chapman, 2004; Gauldie et al., 2002;
elman et al., 2001).
In general, these studies demonstrate that airway inﬂammation,
ung remodeling and responsiveness may  not be directly interre-
ated and suggest that the lack of symptoms in some asthmatic
atients who smoke (mild smokers) does not imply an absence of
ny pathologic changes. Bronchial constriction, for example, could
e attenuated by an increase of collagen content around airways
Bento and Hershenson, 1998; Chen et al., 2003; Niimi et al., 2003;
almans et al., 2000).
In summary, in our experimental model, short-term exposure
o cigarette smoke in mice with pulmonary allergic inﬂammation
esulted in an attenuation of pulmonary inﬂammation and respon-
iveness but led to an increase in lung remodeling.
cknowledgementsThe authors would like to thank to Ângela Santos, Maína
orales, Lucas Faustino, Matheus Costa, Pedro Vieira, Niels Olsen
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